PAG
TMO icon

Private Advisor Group’s Thermo Fisher Scientific TMO Stock Holding History

Private Advisor Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.26M Sell
12,489
-4,125
-25% -$1.98M 0.03% 532
2026
Q1 		$8.17M Sell
16,614
-1,249
-7% -$678K 0.04% 461
2025
Q4 		$10.4M Sell
17,863
-15
-0.1% -$8.48K 0.05% 385
2025
Q3 		$8.67M Sell
17,878
-585
-3% -$272K 0.04% 429
2025
Q2 		$7.49M Sell
18,463
-4,287
-19% -$1.79M 0.04% 434
2025
Q1 		$11.3M Buy
22,750
+1,087
+5% +$589K 0.07% 305
2024
Q4 		$11.3M Sell
21,663
-464
-2% -$255K 0.06% 301
2024
Q3 		$13.7M Buy
22,127
+271
+1% +$160K 0.09% 225
2024
Q2 		$12.1M Buy
21,856
+451
+2% +$258K 0.08% 232
2024
Q1 		$12.4M Sell
21,405
-591
-3% -$332K 0.09% 209
2023
Q4 		$11.7M Buy
21,996
+995
+5% +$482K 0.09% 210
2023
Q3 		$10.6M Sell
21,001
-2,583
-11% -$1.38M 0.1% 203
2023
Q2 		$12.5M Buy
23,584
+578
+3% +$312K 0.11% 184
2023
Q1 		$13.3M Buy
23,006
+996
+5% +$561K 0.13% 170
2022
Q4 		$3M Sell
22,010
-2,452
-10% -$1.3M 0.15% 147
2022
Q3 		$12.4M Sell
24,462
-20,615
-46% -$11.5M 0.14% 150
2022
Q2 		$24.5M Sell
45,077
-543
-1% -$299K 0.22% 97
2022
Q1 		$26.9M Buy
45,620
+727
+2% +$418K 0.21% 99
2021
Q4 		$30M Sell
44,893
-21,165
-32% -$13.2M 0.22% 86
2021
Q3 		$37.7M Buy
66,058
+26,130
+65% +$14.3M 0.24% 78
2021
Q2 		$20.1M Buy
39,928
+570
+1% +$269K 0.18% 115
2021
Q1 		$18M Buy
39,358
+3,319
+9% +$1.58M 0.17% 123
2020
Q4 		$16.8M Buy
36,039
+12,759
+55% +$5.98M 0.17% 117
2020
Q3 		$9.75M Buy
23,280
+812
+4% +$335K 0.13% 171
2020
Q2 		$8.14M Buy
22,468
+1,484
+7% +$497K 0.11% 189
2020
Q1 		$5.95M Sell
20,984
-426
-2% -$134K 0.11% 198
2019
Q4 		$6.96M Sell
21,410
-1,108
-5% -$336K 0.11% 200
2019
Q3 		$6.61M Buy
22,518
+3,966
+21% +$1.14M 0.1% 210
2019
Q2 		$5.44M Buy
18,552
+179
+1% +$49.3K 0.1% 233
2019
Q1 		$5.02M Buy
18,373
+3,207
+21% +$798K 0.1% 216
2018
Q4 		$3.39M Sell
15,166
-1,944
-11% -$456K 0.08% 252
2018
Q3 		$4.18M Buy
17,110
+6,514
+61% +$1.5M 0.09% 230
2018
Q2 		$2.18M Buy
10,596
+2,115
+25% +$449K 0.04% 261
2018
Q1 		$1.75M Buy
8,481
+260
+3% +$54.6K 0.07% 284
2017
Q4 		$1.65M Sell
8,221
-6,352
-44% -$1.22M 0.07% 291
2017
Q3 		$2.81M Buy
14,573
+789
+6% +$143K 0.07% 281
2017
Q2 		$2.45M Buy
13,784
+1
+0% +$168 0.07% 298
2017
Q1 		$2.11M Buy
13,783
+779
+6% +$119K 0.06% 332
2016
Q4 		$1.9M Buy
13,004
+2,005
+18% +$296K 0.06% 312
2016
Q3 		$1.73M Sell
10,999
-1,416
-11% -$218K 0.07% 283
2016
Q2 		$1.85M Buy
12,415
+2,469
+25% +$364K 0.07% 261
2016
Q1 		$1.34M Sell
9,946
-2,314
-19% -$310K 0.06% 300
2015
Q4 		$1.74M Buy
12,260
+2,501
+26% +$334K 0.08% 261
2015
Q3 		$1.19M Buy
9,759
+860
+10% +$112K 0.07% 323
2015
Q2 		$1.16M Buy
8,899
+4,340
+95% +$566K 0.05% 343
2015
Q1 		$613K Buy
4,559
+1,281
+39% +$165K 0.04% 487
2014
Q4 		$411K Sell
3,278
-1,576
-32% -$192K 0.03% 609
2014
Q3 		$591K Buy
4,854
+1,384
+40% +$168K 0.04% 464
2014
Q2 		$409K Buy
+3,470
New +$408K 0.04% 559

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Private Advisor Group's TMO Position: Q2 2026 in Review

Private Advisor Group reduced its Thermo Fisher Scientific (TMO) stake by 25% in Q2 2026, selling an estimated $1.98M and leaving 12,489 shares worth $6.26M. The position accounts for 0.03% of the portfolio, ranked #532.

Private Advisor Group first reported a position in TMO in Q2 2014 and has held it in 49 quarters since. The position peaked at $37.7M in Q3 2021. 1,092 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Private Advisor Group held 12,489 shares of Thermo Fisher Scientific worth $6.26M as of Q2 2026.
  • Private Advisor Group sold 4,125 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.98M.
  • Thermo Fisher Scientific made up 0.03% of Private Advisor Group's portfolio in Q2 2026, its #532 holding.
  • Private Advisor Group first reported a position in Thermo Fisher Scientific in Q2 2014 and has held it in 49 quarters since.
  • Private Advisor Group's Thermo Fisher Scientific position peaked at $37.7M in Q3 2021.
  • 1,092 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.